Apolipoprotein E gene polymorphism as a risk factor for ischemic cerebrovascular disease

Jugoslovenska Medicinska Biohemija

Volumn 23, Issue 3, 2004, Pages 255-264

  Stanković, Sanja ^a,d   Jovanović Marković, Zagorka ^b,e   Majkić Singh, Nada ^a,d   Stanković, Aleksandra ^c   Glišić, Sanja ^c   Živković, Maja ^c   Kostić, Vladimir ^b,e   Alavantić, Dragan ^c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d Institut za Medicinsku Biohemiju   (Yugoslavia)

^e Institut za Nuklearne Nauke   (Serbia)

Author keywords

Apolipoprotein E; Ischemic cerebrovascular disease; Polymorphism

Indexed keywords

APOLIPOPROTEIN E; DNA;

ADULT; AGED; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK; YUGOSLAVIA;

EID: 4644286874     PISSN: 03543447     EISSN: None     Source Type: Journal    
DOI: 10.2298/JMH0403255S     Document Type: Conference Paper

References (43)

1. Hassan A, Markus HS. Genetics and ischaemic stroke. Brain 2000; 123 (9): 1784-812.
2. Siest G, Pillot T, Regis-Bally A, Leininger-Muller B, Steinmetz J, Galteau MM, et al. Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem 1995; 41: 1068-86.
3. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988; 8: 1-21.
4. Wilson PWF, Shaefer EJ, Larson MG, Ordovas JM. Apolipoprotein E alleles and risk of coronary disease: a meta-analysis. Arterioscler. Thromb Vasc Biol 1996; 16: 1250-5.
5. Kunkel LM, Smith KD, Bayer SH. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 1977; 74: 1245-9.
6. Emi M, Wui LL, Robertson MA, Myers RL, Hegele RA, Williams RR, et al. Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics 1988; 3: 373-9.
7. Stanković S, Glišić S, Alavantić D. Apolipoprotein E gene DNA polymorphism in Serbian population. Jugoslov Med Biohem 1999; 18: 9-15.
8. Mahieux F, Bailleul S, Fenelon R, Couderc R, Laruelle P, Gunel M. Prevalence of apolipoprotein E phenotypes in patients with acute ischemic stroke. Stroke 1990; 21: 1-115.
9. Pedro-Botet J, Senti M, Nogues X, Rubies-Prat J, Roquer J, D'Olhaberriague L, Olive J. Lipoprotein and apolipoprotein profile in men with ischemic stroke: Role of Lipoprotein (a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke 1992; 23: 1556-62.
10. Couderc R, Mahieux F, Bailleul S, Fenelon G, Mary R, Fermanian J. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease: a case-control study. Stroke 1993; 24: 661-4.
11. Coria F, Rubio I, Nunez E, Sempere AP, SantaEngarcia N, Bayon C, Cuadrado N. Apolipoprotein E variants in ischemic stroke. Stroke 1995; 26: 2375-6.
12. De Andrade M, Thandi I, Brown S, Gotto A Jr, Patsch W, Boerwinkle E. Relationship of the apolipoprotein E polymorphism with carotid artery atherosclerosis. Am J Hum Genet 1995; 56: 1379-90.
13. Kuusisto J, Mykkanen L, Kervinen K, Kesaniemi YA, Laakso M. Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler Thromb Vasc Biol 1995; 15: 1280-6.
14. Basun H, Corder EH, Guo Z, Lannfelt L, Corder LS, Manton KG, Winblad B, Viitanen M. Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more. Stroke 1996; 27: 1310-5.
15. Hachinski V, Graffagnino C, Beaudry M, Bernier G, Buck C, Donner A, Spence JD, Doig G, Wolfe BM. Lipids and stroke: a paradox resolved. Arch Neurol 1996; 53: 303-8.
16. Terry JG, Howard G, Mercuri M, Bond MG, Crouse JR 3rd. Apolipoprotein E polymorphism is associated with segment-specific extracranial carotid artery intima-media thickening. Stroke 1996; 27: 1755-9.
17. Ferrucci L, Guralnik JM, Pahor M, Harris T, Corti MC, Hyman BT, Wallace RB, Havlik RJ. Apolipoprotein E 2 allele and risk of stroke in the older population. Stroke 1997; 28: 2410-6.
18. Kessler C, Spitzer C, Stauske D, Mende S, Stadlmuller J, Walther R, Rettig R. The apolipoprotein E and β-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease. Arterioscler Thromb Vasc Biol 1997; 17: 2880-4.
19. Nakata Y, Katsuya T, Rakugi H, Takami S, Sato N, Kamide K, Ohishi M, Miki T, Higaki J, Ogihara T. Polymorphism of angiotensin converting enzyme, angiotensinogen, and apolipoprotein E genes in a Japanese population with cerebrovascular disease. Am J Hypertens 1997; 10: 1391-5.
20. Schmidt R, Schmidt H, Fazekas F, Schumacher M, Niederkorn K, Kapeller P, Weinrauch V, Kostner GM. Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study. Stroke 1997; 28: 951-6.
21. Aalto-Setala K, Palomaki H, Miettinen H, Vuorio A, Kuusi T, Raininko R, Salonen O, Kaste M, Kontula K. Genetic risk factors and ischaemic cerebrovascular disease: role of common variation of the genes encoding apolipoproteins and angiotensin-converting enzyme. Ann Med 1998; 30: 224-33.
22. Ji Y, Urakami K, Adachi Y, Maeda M, Isoe K, Nakashima K. Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease. Dement Geriatr Cogn Disord 1998; 9(5): 243-5.
23. Margaglione M, Seripa D, Gravina C, Grandone E, Vecchione G, Cappucci G, Merla G, Papa S, Postiglione A, Di Minno G, Fazio VM. Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke: an Italian case-control study. Stroke 1998; 29: 399-403.
24. McCarron MO, Muir KW, Weir CJ, Dyker AG, Bone I, Nicoll JA, Lees KR. The apolipoprotein E epsilon4 allele and outcome in cerebrovascular disease. Stroke 1998; 29: 1882-7.
25. Peng DQ, Zhao SP, Wang JL. Lipoprotein (a), and apolipoprotein E 4 as independent risk factors for ischemic stroke. J Cardiovasc Risk 1999; 6: 1-6.
26. McCarron MO, Delong D, Alberts MJ. ApoE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology 1999; 12: 53 (6): 1308-11.
27. Catto AJ, McCormack LJ, Mansfield MW, Carter AM, Bamford JM, Robinson P, Grant PJ. Apolipoprotein E polymorphism in cerebrovascular disease. Acta Neurol Scand 2000; 101: 399-404.
28. Kokubo Y, Chowdhury AH, Date C, Yokoyama T, Sobue H, Tanaka H. Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population. Stroke 2000; 31: 1299-1306.
29. Chowdhury AH, Yokoyama T, Kokubo Y, Zaman MM, Haque A, Tanaka H. Apolipoprotein E genetic polymorphism and stroke subtypes in a Bangladeshi hospital-based study. J Epidemiol 2001; 11 (3): 131-8.
30. Frikke-Schmidt R, Nordestgaard BG, Thudium D, Gronholdt MLM, Tybjaerg-Hansen A. ApoE genotype predicts AD and other dementia but not ischemic cerebrovascular disease. Neurology 2001; 56: 194-200.
31. MacLeod MJ, De Lange RP, Breen G, Meiklejohn D, Lemmon H, Clair DS. Lack of association between apolipoprotein E genoype and ischaemic stroke in a Scottish population. Eur J Clin Invest 2001; 31 (7): 570-3.
32. Serteser M, Viskikis S, Ozben T, Herbeth B, Balkan S, Siest G. Lipid profile and apolipoprotein E genotyping in stroke: a case-control study. Neuroscience-Net 2001; 3, article 10015.
33. Slooter AJC, Bots ML, Havekes LM, del Sol AI, Cruts M, Grobbee DE, Hofman A, Van Broeckhoven C, Witteman JCM, van Dujn CM. Apolipoprotein E and carotid artery atherosclerosis: The Rotterdam study. Stroke 2001; 32: 1947-52.
34. Topić E, Šimundić AM, Štefanović M, Demarin V, Vuković V, Lovrenčić-Huzjan A, Žuntar I. Polymorphism of apoprotein E (apoE), methylenetetrahydrofolte reductase (MTHFR) and paraoxonase (PON1) genes in patients with cerebrovascular disease. Clin Chem Lab Med 2001; 39 (4): 346-350.
35. Luthra K, Prasad K, Kumar P, Dwivedi M, Pandey RM, Das N. Apolipoprotein E gene polymorphism in cerebrovascular disease: a case-control study. Clin Genet 2002; 62 (1): 39-44.
36. Szolnoki Z, Somogyvari F, Kondacs A, Szabo M, Fodor L. Evaluation of the interactions of common genetic mutations in stroke subtypes. J Neurol 2002; 249: 1391-7.
37. Souza DRS, Campos BF, de Arruda EF, Yamamoto LJ, Trinidane DM, Tognola WA. Influence of the polymorphism of apolipoprotein E in cerebral vascular disease. Arq Neuropsiquiatr 2003; 61: 7-13.
38. Jin ZQ, Fan YS, Ding J, Chen M, Fan W, Zhang GJ, Zhang BH, Yu SJ, Zhang YS, Ji WF, Zhang JG. Association of apolipoprotein E 4 polymorphism with cerebral infarction in Chinese Han population. Acta Pharmacol Sin 2004; 25 (3): 352-6.
39. Pezzini A, Grassi M, Zotto ED, Bazzoli E, Archetti S, Assanelli D, Akkawi NM, Albertini A, Padovani A. Synergistic effect of apolipoprotein E polymorphisms and cigarette smoking on risk of ischemic stroke in young adults. Stroke 2004; 35: 438-42.
40. Skoog I, Hesse C, Aevarsson O, Landahl S, Wahlstrom J, Fredman P, Blennow K. A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality. J Neurol Neurosurg Psychiatry 1998; 64 (1): 37-43.
41. Ukkola O, Kervinen K, Salmela PI, von Laakso DK, Kesaniemi YA. Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus. Atherosclerosis 1993; 101: 9-15.
42. Vauhkonen I, Niskanen L, Ryynanen M, Voutilainen R, Partanen J, Toyry J, Mercuri M, Rauramaa R, Uusitupa M. Divergent association of apolipoprotein E polymorphism with vascular disease in patients with NIDDM and control subjects. Diabet Med 1997; 14 (9): 748-56.
43. Lim PS, Liu CS, Hong CJ, Wei YH. Prevalence of apolipoprotein E genotypes in ichemic cerebrovascular disease in end-stage renal disease patients. Nephrol Dial Transplant 1997; 12: 1916-20.